Call for application for the position of a National Reference Centre for Human Microbiology for 2025-2029 | Closed

Last updated on 1-5-2024 by Amber Van Laer

Important communication (01/05/2024)

The call for applications for the position of National Reference Centres for Human Microbiology for 2025-2029 has officially closed. If application forms are still received, we will no longer be able to accept them. We thank you for your understanding.  

Context

As described in the Royal Decree of 09/02/2011, a network of National Reference Centres (NRC) for Human Microbiology is established within Belgium and appointed for a duration of 5 years. The current convention period ends on the 31st of December 2024 and the call for applications for the next convention period (1st January 2025 — 31st December 2029) is opening on the 1st of March 2024. The network is funded by RIZIV-INAMI and coordinated by Sciensano in collaboration with the Medical Technical Advisory Board (MTAB). You can find more information regarding the current network of NRCs on the dedicated Sciensano web page.

If you have any questions, please contact us at nrchm@sciensano.be

List of pathogens requiring an NRC for 2025-2029

Below, you can find the list of 40 pathogens or groups of pathogens for which an NRC is foreseen during the upcoming convention period. 

ID List of pathogen(s) 
1 Antibiotic resistant Gram-negative bacilli (MDRO)
2 Arboviruses: West Nile virus, Dengue virus, Yellow Fever virus, Tick-borne encephalitis (TBE) virus, Chikungunya virus, Zika virus
3 Bordetella pertussis
4 Borrelia spp., including Borrelia burgdorferi and Borrelia recurrentis
5 Brucella spp.
6 Burkholderia spp. and other non-fermenters (inert Gram-negative bacilli except for Pseudomonas aeruginosa and Acinetobacter spp.)
7 Campylobacter spp.
8 Clostridioides difficile
9 Clostridium botulinum, Clostridium perfringens and Clostridium tetani
10 Congenital infections: Toxoplasma, Rubella, Cytomegalovirus and Parvovirus B19
11 Coxiella burnetii, Bartonella
12 Enterococci (MDRO)
13 Enterovirus, including polioviruses and parechoviruses
14 Haemophilus influenzae
15 Hantavirus
16 Helicobacter pylori
17 Hepatitis A, B, C, D and E viruses
18 Antiviral resistance Herpesviridae
19 Human papillomavirus
20 Legionella pneumophila
21 Listeria monocytogenes
22 Measles, Mumps and Rubella viruses
23 Mycobacterium spp.
24 Mycosis
25 Neisseria meningitidis
26 Norovirus
27 Rabies virus
28 Respiratory pathogens: adenovirus, coronavirus including SARS, human parainfluenza virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, respiratory syncytial virus (RSV), human metapneumovirus (HMPV), influenza virus
29 Rickettsia, Anaplasma (Ehrlichia)
30 Rotavirus
31 Salmonella/Shigella spp.
32 Staphylococcus aureus
33 Shiga-toxin/verotoxin-producing Escherichia coli (STEC/VTEC)
34 STI (Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium) and mpox
35 Streptococcus agalactiae
36 Streptococcus pneumoniae invasive
37 Streptococcus pyogenes and other beta-hemolytic streptococci non-group B (invasive)
38 Toxigenic corynebacteria
39 Vibrio cholerae and Vibrio parahaemolyticus
40 Yersinia enterocolitica and Yersinia pseudotuberculosis

Timeline

 

Documentation

Below, you can find all the necessary documentation in relation to the NRC call: 

Please note that the documents are susceptible to adjustments. In the exceptional case of modifications to the form during the call, all involved parties will be notified. 

Financial source

QR code

QR code for this page URL